ArticleJournal of health, population, and nutrition2026
Association between serum calcium concentration in patients with osteoarthritis and all-cause mortality and cardiovascular mortality: a retrospective cohort study.
Article in Journal of health, population, and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThis study aimed to clarify between serum calcium and mortality in osteoarthritis (OA) patients using NHANES data (2003-2018).
methodA total of 1,249 adults with OA were included. Mortality outcomes were ascertained through linkage to the National Death Index (NDI). Cox proportional hazards models were used to assess the independent association of serum calcium concentration with the risk of death. We used a two-stage Cox proportional hazards model to elucidate the nonlinear relationship between serum calcium concentration and the risk of death in patients with OA. Stratified analyses were performed to identify patients at higher risk.
resultsDuring follow-up (median: 9.7 years), 220 all-cause deaths occurred (56 CVD-related, 64 cancer-related). After adjusting for relevant variables, serum calcium concentration showed an inverse linear association with all-cause and CVD mortality. Although smoothed curve fitting visually suggested U-shaped and L-shaped patterns for all-cause and CVD mortality, respectively, formal tests for nonlinearity did not reach statistical significance (P for log-likelihood ratio > 0.05). Specifically, the risk was elevated at lower calcium levels and stabilized or showed a non-significant increase at higher levels. In the piecewise linear model, serum calcium below 9.50 mg/dL was inversely associated with all-cause mortality, where each 1 mg/dL increase was associated with a 48% lower risk (HR 0.52, 95% CI: 0.30-0.91). Above 9.50 mg/dL, the association was non-significant (HR 1.09, 95% CI: 0.51-2.35). A similar L-shaped pattern was observed for CVD mortality below the inflection point (HR 0.26, 95% CI: 0.09-0.74). However, formal likelihood ratio tests comparing the threshold model with a linear model did not reach statistical significance (P > 0.05), indicating that the data do not provide strong evidence against a linear association.
conclusionOur primary analysis supports an inverse linear association between serum calcium and mortality in OA patients. Although exploratory analyses revealed potential non-linear patterns visually, these were not statistically confirmed. Therefore, the overall relationship is best characterized as linear within the observed range, with lower serum calcium associated with higher mortality risk. Therefore, these findings highlight a potential optimal range for serum calcium but require verification in future studies designed to confirm nonlinearity and assess the clinical utility of calcium management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.